HPV Hiroyuki Yoshikawa 1 1Department of Obstetrics & Gynecology, Graduate School of Human Comprehensive Sciences, Universuty of Tsukuba Keyword: ヒトパピローマウイルス , 子宮頸癌 , ワクチン pp.1371-1375
Published Date 2010/10/30
DOI https://doi.org/10.11477/mf.1542102449
  • Abstract
  • Look Inside
  • Reference

For cervical cancer prevention, vaccination programs against the two major cancer-causing types (HPV-16/18) were started in Japan. Clinical trials have shown that these vaccines are almost 100% effective in preventing high-grade precancer associated with the HPV types and that these vaccines are safe and well tolerated. The vaccination of females between 10 and 26 years is especially recommended. We can eradicate about 70% of cervical cancers in the not too distant future.

Copyright © 2010, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1367 印刷版ISSN 0485-1420 医学書院